Literature DB >> 17057386

Effective high-dose clonazepam treatment in two patients with opsoclonus and myoclonus: GABAergic hypothesis.

Ales Bartos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057386     DOI: 10.1159/000096494

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  5 in total

Review 1.  An update and review of the treatment of myoclonus.

Authors:  Kelly Mills; Zoltan Mari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

3.  Delayed Opsoclonus-Myoclonus Syndrome After Ovarian Teratoma Resection.

Authors:  Andrea A Jones; Tychicus Chen
Journal:  J Neuroophthalmol       Date:  2021-08-17       Impact factor: 4.415

4.  Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?

Authors:  Vimal Kumar Paliwal; Satish Chandra; Ritu Verma; Jayantee Kalita; Usha K Misra
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

5.  Case Report: Opsoclonus-Myoclonus Syndrome Associated With Contactin-Associated Protein-Like 2 and Acetylcholine Receptor Autoantibodies in the Setting of Non-Small Cell Lung Carcinoma.

Authors:  Christian S Rosenow; Sara Dawit; Luca P Farrugia; Katharine A Henry Ma; Akanksha Sharma; Andrew McKeon; Alyx B Porter; Marie F Grill
Journal:  Neurohospitalist       Date:  2021-05-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.